Skip to main content
SpringerLink
Log in

Histoplasmosis

  • Chapter
Diagnosis and Treatment of Human Mycoses

Part of the book series: Infectious Disease ((ID))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Panackal AA, Hajjeh RA, Cetron MS, Warnock DW. Fungal infections among returning travelers. Clin Infect Dis 2002;35:1088–1095.

    Article  PubMed  Google Scholar 

  2. Chu JH, Feudtner C, Heydon K, Walsh TJ, Zaoutis TE. Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis 2006;42:822–825.

    Article  PubMed  Google Scholar 

  3. Antinori S, Magni C, Nebuloni M et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) 2006;85:22–36.

    Article  Google Scholar 

  4. Newman SL. Interaction of Histoplasma capsulatum with human macrophages, dendritic cells, and neutrophils. Methods Mol Med 2005;118:181–191.

    PubMed  Google Scholar 

  5. Deepe GS. Modulation of infection with Histoplasma capsulatum by inhibition of tumor necrosis factor-alpha activity. Clin Infect Dis 2005;41 (Suppl 3):S204–S207.

    Article  PubMed  CAS  Google Scholar 

  6. Vail GM, Young RS, Wheat LJ, Filo RS, Cornetta K, Goldman M. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002;4:148–151.

    Article  PubMed  CAS  Google Scholar 

  7. Wheat LJ, Conces DJ, Allen S, Blue-Hnidy D, Loyd J. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management. Semin Respir Crit Care Med 2004;25:129–144.

    Article  PubMed  Google Scholar 

  8. Wheat LJ, Kauffman CA. Histoplasmosis. Infect Dis Clin North Am 2003;17:1–19.

    Article  PubMed  Google Scholar 

  9. Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis 2005;7:109–115.

    Article  PubMed  CAS  Google Scholar 

  10. Wood KL, Hage CA, Knox KS, et al. Histoplasmosis after treatment with anti-TNF-alpha therapy. Am J Respir Crit Care Med 2003;167:1279–1282.

    Article  PubMed  Google Scholar 

  11. Wheat J. Histoplasmosis in the acquired immunodeficiency syndrome. Curr Top Med Mycol 1996;7:7–18.

    PubMed  CAS  Google Scholar 

  12. Duncan RA, Von Reyn CF, Alliegro GM, Toossi Z, Sugar AM, Levitz SM. Idiopathic CD4+ T-lymphocytopenia—four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med 1993;328:393–398.

    Article  PubMed  CAS  Google Scholar 

  13. Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 2005;41:e38–e41.

    Article  PubMed  Google Scholar 

  14. Adderson EE. Histoplasmosis in a pediatric oncology center. J Pediatr 2004;144:100–106.

    Article  PubMed  Google Scholar 

  15. Wheat LJ. Current diagnosis of histoplasmosis. Trends Microbiol 2003;11:488–494.

    Article  CAS  Google Scholar 

  16. Wheat LJ, Connolly P, Durkin M, et al. False-positive Histoplasma antigenemia caused by antithymocyte globulin antibodies. Transpl Infect Dis 2004;6:23–27.

    Article  PubMed  CAS  Google Scholar 

  17. Wheat LJ, Connolly P, Durkin M, Book BK, Pescovitz MD. Elimination of false-positive Histoplasma antigenemia caused by human anti-rabbit antibodies in the second generation Histoplasma antigen test. Transpl Infect Dis 2006;8:219-221.

    Article  PubMed  CAS  Google Scholar 

  18. Hage CA, Davis TE, Egan L, et al. Diagnosis of pulmonary histoplasmosis and blastomycosis by detection of antigen in bronchoalveolar lavage fluid using an improved second-generation enzyme-linked immunoassay. Respir Med 2007;101:43–47.

    Article  PubMed  Google Scholar 

  19. Wheat LJ, Musial CE, Jenny-Avital E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 2005;40:844–852.

    Article  PubMed  CAS  Google Scholar 

  20. Wheat J, Sarosi G, McKinsey D, et al. Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis 2000;30: 688–695.

    Article  PubMed  CAS  Google Scholar 

  21. Johnson PC, Wheat LJ, Cloud GA, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002;137:105–109.

    PubMed  CAS  Google Scholar 

  22. Goldman M, Zackin R, Fichtenbaum CJ, et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis 2004;38:1485–1489.

    Article  PubMed  Google Scholar 

  23. Connolly P, Wheat LJ, Schnizlein-Bick C, et al. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob Agents Chemother 2000;44: 2604–2608.

    Article  PubMed  CAS  Google Scholar 

  24. Restrepo A, Tobon A, Clark B, et al. Salvage treatment of histoplasmosis with posaconazole. J Infect 2007;54:319–327.

    Article  PubMed  Google Scholar 

  25. Wheat LJ, Connolly P, Smedema M, Brizendine E, Hafner R. Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. Clin Infect Dis 2001;33:1910–1913.

    Article  PubMed  CAS  Google Scholar 

  26. Wheat LJ, Connolly P, Smedema M, et al. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole. J Antimicrob Chemother 2006;57:1235–1239.

    Article  PubMed  CAS  Google Scholar 

  27. Kohler S, Wheat LJ, Connolly P, et al. Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model. Antimicrob Agents Chemother 2000;44:1850–1854.

    Article  PubMed  CAS  Google Scholar 

Suggested Readings

  • Goldman M, Zackin R, Fichtenbaum CJ, et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis 2004;38:1485–1489.

    Article  PubMed  Google Scholar 

  • Johnson PC, Wheat LJ, Cloud GA, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002;137:105–109.

    PubMed  CAS  Google Scholar 

  • Lee JH, Slifman NR, Gershon SK, et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 2002;46:2565–2570.

    Article  PubMed  CAS  Google Scholar 

  • Limaye AP, Connolly PA, Sagar M, et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med 2000;343:1163–1166.

    Article  PubMed  CAS  Google Scholar 

  • Vail GM, Young RS, Wheat LJ, Filo RS, Cornetta K, Goldman M. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002;4:148–151.

    Article  PubMed  CAS  Google Scholar 

  • Wheat LJ. Histoplasmosis: a review for clinicians from non-endemic areas. Mycoses 2006;49:274–282.

    Article  PubMed  Google Scholar 

  • Wheat LJ, Conces DJ, Jr., Allen S, Blue-Hnidy D, Loyd J. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management. Semin Respir Crit Care Med 2004;25:129–144.

    Article  PubMed  Google Scholar 

  • Wheat LJ, Musial CE, Jenny-Avital E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 2005;40:844–852.

    Article  PubMed  CAS  Google Scholar 

  • Woods JP. Histoplasma capsulatum molecular genetics, pathogenesis, and responsiveness to its environment. Fungal Genet Biol 2002;35:81—97.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. L. Joseph Wheat MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicholas G. Conger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Infectious Disease Service, Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, TX; F. Edward Hébert School of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD

    Duane R. Hospenthal MD,PhD

  2. Fungus Testing Laboratory, Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, TX

    Michael G. Rinaldi PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press Inc.

About this chapter

Cite this chapter

Wheat, L.J., Conger, N.G. (2008). Histoplasmosis. In: Hospenthal, D.R., Rinaldi, M.G. (eds) Diagnosis and Treatment of Human Mycoses. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-59745-325-7_17

Download citation

Publish with us

Policies and ethics

Search

Navigation